🇺🇸 FDA

Company profile · Sponsor

Minoryx

Minoryx Therapeutics S.L.

E1F2890 · EMA pharma EU
Pipeline
4
Drugs
0
Patents
0

Quick answer

Minoryx (E1F2890) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E1F2890
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (4)

Search pipeline →

  1. The MIN-102 Placebo is supplied as an oral suspension with similar appearance to MIN-102 drug product. MIN-102 placebo oral suspension is packaged in an amber glass bottle with filled volume based on the required clinical dose.

    Minoryx

    Cerebral adrenoleukodystrophy (cALD)

    phase 3 small molecule active

    1 trial

  2. AN OPEN-LABEL, MULTICENTER STUDY IN MALE PEDIATRIC PATIENTS WITH CEREBRAL X-LINKED ADRENOLEUKODYSTROPHY (CALD) TO ASSESS THE EFFECTS OF MIN-102 TREATMENT ON DISEASE PROGRESSION PRIOR TO HUMAN STEM CELL TRANSPLANT (HSCT)

    Minoryx

    CEREBRAL X-LINKED ADRENOLEUKODYSTROPHY (CALD)

    phase 2 other active

    1 trial

  3. The min-102 placebo is supplied as an oral suspension with similar appearance to min-102 drug product. min-102 placebo oral suspension is packaged in an amber glass bottle with filled volume based on the required clinical dose

    Minoryx

    Rett Syndrome

    phase 2 small molecule active

    1 trial

  4. Finlepsin 200 retard, 200 mg, tabletki o przedłużonym uwalnianiu, Orungal, 100 mg, kapsułki, Gemfibrozilo STADA 600 mg comprimidos recubiertos con película EFG, Neurotop retard 300, 300 mg, tabletki o przedłużonym uwalnianiu

    Minoryx

    Adrenoleukodystrophy

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Minoryx?

Minoryx (E1F2890) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Minoryx sponsor?

We track 4 ClinicalTrials.gov-linked programs for Minoryx, including The MIN-102 Placebo is supplied as an oral suspension with similar appearance to MIN-102 drug product. MIN-102 placebo oral suspension is packaged in an amber glass bottle with filled volume based on the required clinical dose. and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Minoryx company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.